e-ISSN: Pending
Negative / Null Result ReportOpen accessImmunology and Microbiology· cited by 285

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

Joris D. Veltman; Margaretha Lambers; Menno van Nimwegen; Rudi W. Hendriks; Henk C. Hoogsteden; Joachim G.J.V. Aerts; Joost P. Hegmans · 2010 · BMC Cancer

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature cells that accumulates in tumour-bearing hosts. These cells are induced by tumour-derived factors (e.g. prostaglandins) and have a critical role in immune suppression. MDSC suppress T and NK cell function via increased expression of arginase I and production of reactive oxygen species (ROS) and nitric oxide (NO). Immune suppression by MDSC was found to be one of the main factors for immunotherapy insufficiency. Here we investigate if the in vivo immunoregulatory function of MDSC can be reversed by in

Abstract by Joris D. Veltman; Margaretha Lambers; Menno van Nimwegen; Rudi W. Hendriks; Henk C. Hoogsteden; Joachim G.J.V. Aerts; Joost P. Hegmans, BMC Cancer (2010) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1186/1471-2407-10-464